Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Selenium
Therapeutic Area : Oncology
Study Phase : Undisclosed
Sponsor : National Center for Research and Development, Poland | IQ Pharma S.A. | West Pomeranian University of Technology | Vipharm S.A.
Deal Size : Inapplicable
Deal Type : Inapplicable
Prevention of Female Cancers by Optimization of Selenium Levels in the Organism.
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
July 10, 2019
Lead Product(s) : Selenium
Therapeutic Area : Oncology
Highest Development Status : Undisclosed
Sponsor : National Center for Research and Development, Poland | IQ Pharma S.A. | West Pomeranian University of Technology | Vipharm S.A.
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Selenium
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Fera Science Ltd.
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
December 10, 2018
Lead Product(s) : Selenium
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Fera Science Ltd.
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Selenium
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Biosyn | Boryung Pharmaceutical Co., Ltd
Deal Size : Inapplicable
Deal Type : Inapplicable
Selenium Replacement and Serum Selenium Level in Severe Sepsis and Septic Shock Patients
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
May 18, 2012
Lead Product(s) : Selenium
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Biosyn | Boryung Pharmaceutical Co., Ltd
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Selenium
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Undisclosed
Sponsor : Ostergotland County Council | The Swedish Research Council | Pharma Nord
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
September 30, 2011
Lead Product(s) : Selenium
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Undisclosed
Sponsor : Ostergotland County Council | The Swedish Research Council | Pharma Nord
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Selenium
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Global Benefit Canada | University of Ottawa | Wilfrid Laurier University | Kibagabaga District Hospital | Kinyinya Health Centre
Deal Size : Inapplicable
Deal Type : Inapplicable
Rwanda Selenium Supplementation Clinical Trial
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
April 04, 2011
Lead Product(s) : Selenium
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Global Benefit Canada | University of Ottawa | Wilfrid Laurier University | Kibagabaga District Hospital | Kinyinya Health Centre
Deal Size : Inapplicable
Deal Type : Inapplicable